# Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

> **NCT00613080** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 79 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** oxaliplatin
- **PROCEDURE:** resection
- **RADIATION:** radiation therapy
- **DRUG:** FOLFOX

## Key facts

- **NCT ID:** NCT00613080
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-01
- **Final completion:** 2016-12
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2018-09-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613080, "Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00613080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*